MesoGold ® 20 ppm Colloidal Gold 250 mL/8.45 Oz
Features
- Colloid Gold has been reported to have been very effective in relieving symptoms of Rheumatoid arthritis.
- It has been associated with improved mental function, and faster reaction time as well as other cognitive functions.
- Improved hand to eye coordination in sports activities.
- Improved energy levels and sense of well-being.
- Improved memory.
Product Details
- ASIN: B00125L33A
- Item model number: MesoGold 250 Ml
- Average Customer Review: Customer Reviews
Product Description
20 PPM Concentration:
Purest Colloids colloidal gold is ruby red in color because gold particles cause the red light spectrum to be refracted, this is why gold is used in the manufacture of what is known as cranberry glass. Colloidal gold has been shown to be effective in improving mental function, and has been experimented with in the treatment of Rheumatoid Arthritis All other products called colloid gold tested by Purest Colloids were found to be Gold Chloride this has been shown to be neurotoxic ( toxic to nerve cells ) IONIC GOLD PRODUCTS SHOULD NOT BE USED. Some manufacturers and internet quacks describe how you can make colloid gold at home with an electrolysis machines DON'T BELIEVE THEM!
Dosage
The nominal adult dosage for colloidal gold is one tablespoon (15mL) but optimum dosage must be determined for each individual. Most adults will find their optimum dosage will be between 1 and 4 tablespoons. Some power users take 6 to 8 tablespoons daily. To find your optimum dosage, start with two tablespoons daily for one week, then double to 4 tablespoons for one week. Then cut back one tablespoon at a time and try the new dosage for one week to find what dosage suites your individual requirements. For children start with a dosage of one teaspoon (5 mL) for each 70 pounds of body weight and determine the optimum dosage by doubling the dosage after one week. Individual requirements will vary so actual dosage must be determined by trial and error. A large dosage is not harmful.
